Todays Report: The Alpine Partners VI LLC Acquires 2,097 Shares of Clorox Co. (CLX)

The Alpine Partners VI LLC Acquires 2,097  Shares of Clorox Co. (CLX)

Alpine Partners VI LLC acquired a new stake in shares of Clorox Co. (NYSE:CLX) during the second quarter, Holdings Channel reports. The institutional investor acquired 2,097 shares of the company’s stock, valued at approximately $290,000.

Other large investors have also recently added to or reduced their stakes in the company. OMERS ADMINISTRATION Corp increased its stake in shares of Clorox by 10.0% in the first quarter. OMERS ADMINISTRATION Corp now owns 8,800 shares of the company’s stock valued at $1,109,000 after buying an additional 800 shares during the period. Canada Pension Plan Investment Board increased its stake in shares of Clorox by 271.1% in the first quarter. Canada Pension Plan Investment Board now owns 153,507 shares of the company’s stock valued at $19,351,000 after buying an additional 112,145 shares during the period. Credit Agricole S A increased its stake in shares of Clorox by 93.7% in the first quarter. Credit Agricole S A now owns 314,490 shares of the company’s stock valued at $39,645,000 after buying an additional 152,129 shares during the period. Carnick & Kubik LLC bought a new stake in shares of Clorox during the first quarter valued at about $794,000. Finally, Aviva PLC increased its stake in shares of Clorox by 0.8% in the first quarter. Aviva PLC now owns 66,116 shares of the company’s stock valued at $8,335,000 after buying an additional 500 shares during the period. Hedge funds and other institutional investors own 70.21% of the company’s stock.

Clorox Co. (NYSE:CLX) opened at 122.65 on Friday. Clorox Co. has a 12 month low of $119.23 and a 12 month high of $140.47. The stock has a market cap of $15.88 billion, a PE ratio of 24.93 and a beta of 0.29. The stock’s 50 day moving average price is $126.61 and its 200-day moving average price is $129.88.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period last year, the business earned $1.44 EPS. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. Analysts anticipate that Clorox Co. will post $5.49 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Investors of record on Wednesday, October 26th will be given a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is presently 64.91%.

Several equities research analysts recently issued reports on the company. B. Riley reiterated a “neutral” rating and set a $109.00 price target on shares of Clorox in a report on Tuesday, August 9th. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a report on Tuesday, July 12th. Goldman Sachs Group Inc. reiterated a “neutral” rating and set a $130.00 price target on shares of Clorox in a report on Thursday, August 4th. Citigroup Inc. upped their price target on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a report on Monday, August 8th. Finally, Jefferies Group reissued a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $128.90.

In other Clorox news, EVP Laura Stein sold 38,882 shares of Clorox stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the sale, the executive vice president now owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Jon M. Balousek sold 5,136 shares of Clorox stock in a transaction on Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the completion of the sale, the senior vice president now directly owns 15,384 shares of the company’s stock, valued at approximately $2,017,457.76. The disclosure for this sale can be found here. Corporate insiders own 0.74% of the company’s stock.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Related posts

Leave a Comment